News: Pharma

News: Pharma

Pharmaceutical Industry News, Drugs, Nutraceuticals, Vitamins, and Related

News: Pharma

News: Pharma
Pharmaceutical Industry News, Drugs, Nutraceuticals, Vitamins, and Related

CMI's Mike Mabey to Co-Present with Pfizer Specialty at 2012 PMRG Annual National Conference

ATLANTA, Ga. /eNewsChannels/ -- CMI's Mike Mabey, vice president, client solutions, and Jarod Ricci, senior manager, market analytics, Pfizer (NYSE:PFE), will present 'Using Information-Seeking Behavior to Drive Segment-Specific Communication Strategies' at the 2012 PMRG (Pharmaceutical Marketing Research Group) Annual National Conference.

OCuSOFT(R) Lid Scrub(TM) PLUS Now Available in CVS Pharmacies

RICHMOND, Texas -- CYNACON / OCuSOFT (OCuSOFT(R), Inc.), a company specializing in ophthalmic research, development and supply to ophthalmologists and optometrists, is pleased to...
Paragon BioTeck Inc

Ruling by USPTO Affirms Patent Claim for Paragon BioTeck’s R-Phenylephrine Hydrochloride Formulation

eNewsChannels NEWS: (PORTLAND, Ore.,) -- Paragon BioTeck, Inc. announces a monumental ruling handed down by the United States Patent and Trademark Office (USPTO) affirming claims made by Paragon in the patent for its R-phenylephrine hydrochloride formulation. Paragon is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies.

Paragon BioTeck's FDA Approved Phenylephrine Hydrochloride Ophthalmic Solution Readily Available through Bausch + Lomb

PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, announces its FDA approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil, is readily available through Bausch + Lomb.

BIO Investor Forum: Epeius Biotechnologies Investment Opportunity

SAN FRANCISCO, Calif. -- Epeius Biotechnologies Corporation (www.epeiusbiotech.com), an emerging leader in the field of targeted genetic medicine, announced today that Frederick L. Hall,...

Epeius Bio's Rexin-G® Receives High-tech Validation as Strategic Anti-cancer Agent

SAN MARINO, Calif. -- Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, gained international validation of the cutting-edge science...

Multi-Tier Micro Plate System announced by Laboratory Supply Distributors Corp.

VINELAND, N.J. /eNewsChannels/ -- Designed for analytical research and clinical diagnostic testing, Laboratory Supply Distributors Corp. announces the 96-Well Multi-Tier™ Micro Plate System. Its unique, patented design allows for more flexibility and ease of use.
Extreme Muscle Products

Extreme Muscle Products Launches Q-Meric, its First Synergistic Formulation

eNewsChannels NEWS: (AURORA, Colo.) -- Extreme Muscle Products (EMP) have announced the launch of its first formulation available for purchase, a product called Q-Meric. EMP is a newly created Colorado-based company focusing on health, wellness and athletic performance, with an emphasis on products that have synergistic effects.

Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes

SAN MARINO, Calif. -- ASCO 2008 -- Epeius Biotechnologies announced today that the results of a Phase I Feasibility Study of sequential targeted gene...

Ophthalmic Pharmaceuticals Company Paragon BioTeck Receives CE Mark Approval on Comfortear Lacrisolve Absorbable Punctum Plug

PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today that it has received CE mark approval for the recently FDA cleared Comfortear Lacrisolve Absorbable Punctum Plug. CE mark approval is recognized and associated with safety and performance in multiple countries.

WHAT'S NEWS